Skip to main content
Clinical Trials/NL-OMON47792
NL-OMON47792
Completed
Phase 2

A pilot study to investigate the functionality of intra-vaginal glucose sensor in vagina.<br> - Pilot Study intra-vaginal LiGalli ring * glucose sensor device

igalli BV0 sites5 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
igalli BV
Enrollment
5
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
igalli BV

Eligibility Criteria

Inclusion Criteria

  • \* Subject is \> 18 years old on the date she signed the informed consent;
  • \* Subject is taking oral contraceptive birth control (excluding vaginal contraceptive devices) and not menstruating;
  • \* Diagnosed diabetes type 1;
  • \* Wearing a CGM sensor;
  • \* Signed informed consent.

Exclusion Criteria

  • \* Subjects having any historic vaginal disease;
  • \* Pregnant subjects;
  • \* Subjects having their menstrual cycles;
  • \* Not able or willing to comply to the protocol;
  • \* Subjects with signs/ symptoms of any additional disease except diabetes (medical judgement and/or medication history).

Outcomes

Primary Outcomes

Not specified

Similar Trials